Literature DB >> 22341290

5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence.

L Brubaker1, H E Richter, P A Norton, M Albo, H M Zyczynski, T C Chai, P Zimmern, S Kraus, L Sirls, J W Kusek, A Stoddard, S Tennstedt, E Ann Gormley.   

Abstract

PURPOSE: We characterized continence, satisfaction and adverse events in women at least 5 years after Burch urethropexy or fascial sling with longitudinal followup of randomized clinical trial participants.
MATERIALS AND METHODS: Of 655 women who participated in a randomized surgical trial comparing the efficacy of the Burch and sling treatments 482 (73.6%) enrolled in this long-term observational study. Urinary continence status was assessed yearly for a minimum of 5 years postoperatively. Continence was defined as no urinary leakage on a 3-day voiding diary, and no self-reported stress incontinence symptoms and no stress incontinence surgical re-treatment.
RESULTS: Incontinent participants were more likely to enroll in the followup study than continent patients (85.5% vs 52.2%) regardless of surgical group (p<0.0001). Overall the continence rates were lower in the Burch urethropexy group than in the fascial sling group (p=0.002). The continence rates at 5 years were 24.1% (95% CI 18.5 to 29.7) vs 30.8% (95% CI 24.7 to 36.9), respectively. Satisfaction at 5 years was related to continence status and was higher in women undergoing sling surgery (83% vs 73%, p=0.04). Satisfaction decreased with time (p=0.001) and remained higher in the sling group (p=0.03). The 2 groups had similar adverse event rates (Burch 10% vs sling 9%) and similar numbers of participants with adverse events (Burch 23 vs sling 22).
CONCLUSIONS: Continence rates in both groups decreased substantially during 5 years, yet most women reported satisfaction with their continence status. Satisfaction was higher in continent women and in those who underwent fascial sling surgery, despite the voiding dysfunction associated with this procedure. Copyright Â
© 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22341290      PMCID: PMC3586411          DOI: 10.1016/j.juro.2011.11.087

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  A prospective randomized study comparing modified Burch retropubic urethropexy and suburethral sling for treatment of genuine stress incontinence with low-pressure urethra.

Authors:  P K Sand; H Winkler; D W Blackhurst; P J Culligan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

Review 2.  Complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices.

Authors:  Giacomo Novara; Antonio Galfano; Rafael Boscolo-Berto; Silvia Secco; Stefano Cavalleri; Vincenzo Ficarra; Walter Artibani
Journal:  Eur Urol       Date:  2007-11-08       Impact factor: 20.096

3.  Design of the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr).

Authors:  Sharon Tennstedt
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

4.  The epidemiology of urinary incontinence in older women: incidence, progression, and remission.

Authors:  Karen L Lifford; Mary K Townsend; Gary C Curhan; Neil M Resnick; Francine Grodstein
Journal:  J Am Geriatr Soc       Date:  2008-05-19       Impact factor: 5.562

5.  Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group.

Authors:  S A Shumaker; J F Wyman; J S Uebersax; D McClish; J A Fantl
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

6.  Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence.

Authors:  Karen Ward; Paul Hilton
Journal:  BMJ       Date:  2002-07-13

7.  Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up.

Authors:  K L Ward; P Hilton
Journal:  BJOG       Date:  2007-10-25       Impact factor: 6.531

8.  Burch colposuspension versus fascial sling to reduce urinary stress incontinence.

Authors:  Michael E Albo; Holly E Richter; Linda Brubaker; Peggy Norton; Stephen R Kraus; Philippe E Zimmern; Toby C Chai; Halina Zyczynski; Ananias C Diokno; Sharon Tennstedt; Charles Nager; L Keith Lloyd; MaryPat FitzGerald; Gary E Lemack; Harry W Johnson; Wendy Leng; Veronica Mallett; Anne M Stoddard; Shawn Menefee; R Edward Varner; Kimberly Kenton; Pam Moalli; Larry Sirls; Kimberly J Dandreo; John W Kusek; Leroy M Nyberg; William Steers
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

9.  Randomised trial of laparoscopic Burch colposuspension versus tension-free vaginal tape: long-term follow up.

Authors:  J E Jelovsek; M D Barber; M M Karram; M D Walters; M F R Paraiso
Journal:  BJOG       Date:  2008-01       Impact factor: 6.531

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  13 in total

1.  5-year longitudinal followup after retropubic and transobturator mid urethral slings.

Authors:  Kimberly Kenton; Anne M Stoddard; Halina Zyczynski; Michael Albo; Leslie Rickey; Peggy Norton; Clifford Wai; Stephen R Kraus; Larry T Sirls; John W Kusek; Heather J Litman; Robert P Chang; Holly E Richter
Journal:  J Urol       Date:  2014-08-23       Impact factor: 7.450

Review 2.  Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse.

Authors:  M Boennelycke; S Gras; G Lose
Journal:  Int Urogynecol J       Date:  2012-09-01       Impact factor: 2.894

Review 3.  Mid-urethral sling operations for stress urinary incontinence in women.

Authors:  Abigail A Ford; Lynne Rogerson; June D Cody; Patricia Aluko; Joseph A Ogah
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

4.  Renaissance of the autologous pubovaginal sling.

Authors:  Gamal M Ghoniem; Diaa E E Rizk
Journal:  Int Urogynecol J       Date:  2017-11-22       Impact factor: 2.894

5.  Reply to Wael Agur letter to the editor re: Gamal Ghoniem and Diaa Rizk, "Renaissance of the autologous pubovaginal sling" International Urogynecology Journal, 29 (2) 177-178.

Authors:  Gamal Ghoniem
Journal:  Int Urogynecol J       Date:  2018-03-12       Impact factor: 2.894

6.  Patient related factors associated with long-term urinary continence after Burch colposuspension and pubovaginal fascial sling surgeries.

Authors:  Holly E Richter; Linda Brubaker; Anne M Stoddard; Yan Xu; Halina M Zyczynski; Peggy Norton; Larry T Sirls; Stephen R Kraus; Toby C Chai; Philippe Zimmern; E Ann Gormley; John W Kusek; Michael E Albo
Journal:  J Urol       Date:  2012-06-15       Impact factor: 7.450

Review 7.  Open retropubic colposuspension for urinary incontinence in women.

Authors:  Marie Carmela M Lapitan; June D Cody; Atefeh Mashayekhi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

8.  Two-Year Results of Burch Compared With Midurethral Sling With Sacrocolpopexy: A Randomized Controlled Trial.

Authors:  Emanuel C Trabuco; Brian J Linder; Christopher J Klingele; Roberta E Blandon; John A Occhino; Amy L Weaver; Michaela E McGree; John B Gebhart
Journal:  Obstet Gynecol       Date:  2018-01       Impact factor: 7.661

Review 9.  Surgical management of female SUI: is there a gold standard?

Authors:  Ashley Cox; Sender Herschorn; Livia Lee
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

10.  Urethral support in female urinary continence part 1: dynamic measurements of urethral shape and motion.

Authors:  Megan R Routzong; Cecilia Chang; Roger P Goldberg; Steven D Abramowitch; Ghazaleh Rostaminia
Journal:  Int Urogynecol J       Date:  2021-04-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.